BIOXCEL THERAPEUTICS (BTAI) insider trading activity (SEC Form 4). Over the trailing 90 days, BTAI insiders filed 0 purchases totalling $0 and 4 sales totalling $43K — net SELLING of $43K. Most recent filing: May 22, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.
| Filed | Insider | Role | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|---|
| May 22, 2026 | Mehta Vimal | CEO, Pres | S SaleOE | — | $1.09 | $21K | filing |
| May 22, 2026 | Steinhart Richard I | CFO | S SaleOE | — | $1.09 | $7K | filing |
| May 22, 2026 | Rodriguez Javier | See Remarks | S SaleOE | — | $1.08 | $7K | filing |
| May 22, 2026 | Yocca Frank | Chief Scientific Officer | S SaleOE | — | $1.09 | $7K | filing |